AMENDED AND RESTATED EXCLUSIVE SUPPLY AGREEMENTAmended and Restated Exclusive Supply Agreement • April 26th, 2024 • Clene Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED EXCLUSIVE SUPPLY AGREEMENT (this “Agreement”), dated as of April 25, 2024 (the “Effective Date”), is entered into by and between CLENE NANOMEDICINE, INC., a Delaware corporation having its principal place of business at 3615 Millrock Dr., Salt Lake City, Utah 84121 (“Seller”), and 4LIFE RESEARCH, LLC, a Utah limited liability company having its principal place of business at 9850 S. 300 W., Sandy, UT 84070 (“Buyer”, and together with Seller, the “Parties”, and each, a “Party”).
AMENDED AND RESTATED EXCLUSIVE SUPPLY AGREEMENTAmended and Restated Exclusive Supply Agreement • September 25th, 2003 • Cree Inc • Semiconductors & related devices • North Carolina
THIS AMENDED AND RESTATED EXCLUSIVE SUPPLY AGREEMENT (this “Agreement”) is made and entered into effective as of the 6th day of June, 1997, by and between CREE RESEARCH, INC. (“Cree”), a North Carolina corporation having its principal offices at 2810 Meridian Parkway, Suite 144, Durham, North Carolina, 27713, and C3, INC. (“C3”), a North Carolina corporation formerly known as C3 Diamante, Inc. and having its principal offices at P.O. Box 13533, Research Triangle Park, North Carolina 27709-3533.
